Comparison of Metformin and Berberine in PCOD patients

Effects of Lifestyle Modification with Myoinositol and Berberine versus Myoinositol and Metformin in Women with Polycystic Ovary Syndrome: A Prospective Randomized Study: A case report - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/04/085859

Enrollment

240

Registered

2025-04-28

Start date

Unknown

Completion date

Unknown

Last updated

2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E282- Polycystic ovarian syndrome

Interventions

Control Intervention1: Myoinositol and Berberine: Medication has been prescribed for 3 months with diet and lifestyle modificationand Improvement is noted in PCOS parameters at the end of 3 months Co

Eligibility

Inclusion criteria

Inclusion criteria: BMI 18 to 35 PCOS as defined by Rotterdams criteria and all 4 phenotypes Mild to moderate male factor TMSC more 3 million

Exclusion criteria

Exclusion criteria: Endometriosis More than 10 years of infertility Low ovarian reserve Severe male factor infertility Bilateral tubal block DM Patients already on the same medications prior to consultation

Design outcomes

Primary

Measure	Time frame
Clinical, Metabolic, hormonal parametersTimepoint: 3 months	—

Secondary

Measure	Time frame
To assess improvement in cycle regularity and rate of spontaneous conceptionTimepoint: at start of study and at the end of three months	—

Countries

India

Contacts

Public ContactDr Sathyapriya Balasubramaniyan

A4 Hospital and Fertility centre Pvt Ltd

dr_sathyapriya@a4hospital.com9884339538

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026